4//SEC Filing
Hirsch Stanley 4
Accession 0001209191-20-015195
CIK 0001606645other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:32 PM ET
Size
6.0 KB
Accession
0001209191-20-015195
Insider Transaction Report
Form 4
Hirsch Stanley
Director
Transactions
- Award
Ordinary Shares
2020-02-27+42,493→ 111,858 total
Holdings
- 182,500(indirect: See footnote)
Ordinary Shares
Footnotes (3)
- [F1]This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
- [F2]The ordinary shares underlying this restricted share unit award vest over a 12 month period, in equal, quarterly installments, ending February 27, 2021.
- [F3]Securities are held by ZEAS Technology and Science Management Ltd., a company beneficially owned by Stanley Hirsch.
Documents
Issuer
Foamix Pharmaceuticals Ltd.
CIK 0001606645
Entity typeother
Related Parties
1- filerCIK 0001727864
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:32 PM ET
- Size
- 6.0 KB